Unilateral idiopathic neuroretinitis following Pfizer-BioNTech COVID-19 vaccine: a case report

Résumé fourni par la source

This case report describes a temporal relationship of unilateral neuroretinitis following the second Pfizer-BioNTech COVID-19 (Pfizer) vaccine. A 16-year-old male of mixed ethnicity presented with gradual loss of vision and pain on eye movement in his left eye 12 days after his second Pfizer vaccine. His visual acuity in the left eye was counting fingers at half a meter. There was optic nerve head swelling and macular exudates in a star-shaped pattern with peripapillary and foveal subretinal fluid consistent with left neuroretinitis. His serological and radiologic investigations were negative for any alternative aetiology. He was commenced on doxycycline, rifampicin, and oral prednisone on a tapering dose. Four months after presentation, his left eye vision improved to 6/24-2; limited by loss to the outer retinal layers over the fovea. The close proximity of the second Pfizer vaccine dose poses a temporal association with plausible causation.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.